These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17048503)

  • 1. Development and evaluation of emulsion-liposome blends for resveratrol delivery.
    Hung CF; Chen JK; Liao MH; Lo HM; Fang JY
    J Nanosci Nanotechnol; 2006; 6(9-10):2950-8. PubMed ID: 17048503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsion.
    Hung CF; Fang CL; Liao MH; Fang JY
    Int J Pharm; 2007 Apr; 335(1-2):193-202. PubMed ID: 17129692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the formulation design of acoustically active lipospheres as carriers for drug delivery.
    Fang JY; Hung CF; Liao MH; Chien CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):67-75. PubMed ID: 17320362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarriers enhance the transdermal bioavailability of resveratrol: In-vitro and in-vivo study.
    Tsai MJ; Lu IJ; Fu YS; Fang YP; Huang YB; Wu PC
    Colloids Surf B Biointerfaces; 2016 Dec; 148():650-656. PubMed ID: 27697739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol.
    Basavaraj S; Betageri GV
    Expert Opin Drug Deliv; 2014 Apr; 11(4):493-503. PubMed ID: 24456117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability, biocompatibility and antioxidant activity of PEG-modified liposomes containing resveratrol.
    Caddeo C; Pucci L; Gabriele M; Carbone C; Fernàndez-Busquets X; Valenti D; Pons R; Vassallo A; Fadda AM; Manconi M
    Int J Pharm; 2018 Mar; 538(1-2):40-47. PubMed ID: 29294324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanodesign of olein vesicles for the topical delivery of the antioxidant resveratrol.
    Pando D; Caddeo C; Manconi M; Fadda AM; Pazos C
    J Pharm Pharmacol; 2013 Aug; 65(8):1158-67. PubMed ID: 23837583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems.
    Sessa M; Balestrieri ML; Ferrari G; Servillo L; Castaldo D; D'Onofrio N; Donsì F; Tsao R
    Food Chem; 2014 Mar; 147():42-50. PubMed ID: 24206683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A self-microemulsifying drug delivery system to overcome intestinal resveratrol toxicity and presystemic metabolism.
    Seljak KB; Berginc K; Trontelj J; Zvonar A; Kristl A; Gašperlin M
    J Pharm Sci; 2014 Nov; 103(11):3491-3500. PubMed ID: 25103361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility.
    Bolko K; Zvonar A; Gašperlin M
    Drug Dev Ind Pharm; 2014 Jan; 40(1):102-9. PubMed ID: 23301796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation.
    Nallamothu R; Wood GC; Pattillo CB; Scott RC; Kiani MF; Moore BM; Thoma LA
    AAPS PharmSciTech; 2006 Apr; 7(2):E32. PubMed ID: 16796350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics.
    Singh A; Ahmad I; Ahmad S; Iqbal Z; Ahmad FJ
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1524-36. PubMed ID: 26902951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Antioxidant Capacity of Optimization of a Self-Microemulsifying Drug Delivery System for Resveratrol.
    Chen Y; Zhang H; Yang J; Sun H
    Molecules; 2015 Nov; 20(12):21167-77. PubMed ID: 26633319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical delivery of 5-aminolevulinic acid from water-in-oil nano/submicron-emulsion systems.
    Fang JY; Wu PC; Fang CL; Chen CH
    J Pharm Sci; 2010 May; 99(5):2375-85. PubMed ID: 19921749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomes as carriers of the lipid soluble antioxidant resveratrol: evaluation of amelioration of oxidative stress by additional antioxidant vitamin.
    Vanaja K; Wahl MA; Bukarica L; Heinle H
    Life Sci; 2013 Dec; 93(24):917-23. PubMed ID: 24177602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of
    Scalia S; Zampino MR; Trotta V; Bianchi A
    Pharmazie; 2017 Apr; 72(4):200-204. PubMed ID: 29441987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of liposome encapsulation technique to improve anti-carcinoma effect of resveratrol.
    Lu XY; Hu S; Jin Y; Qiu LY
    Drug Dev Ind Pharm; 2012 Mar; 38(3):314-22. PubMed ID: 21851312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant activity of resveratrol-loaded liposomes in vivo.
    Ethemoglu MS; Seker FB; Akkaya H; Kilic E; Aslan I; Erdogan CS; Yilmaz B
    Neuroscience; 2017 Aug; 357():12-19. PubMed ID: 28577913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing delivery and cytotoxicity of resveratrol through a dual nanoencapsulation approach.
    Soo E; Thakur S; Qu Z; Jambhrunkar S; Parekh HS; Popat A
    J Colloid Interface Sci; 2016 Jan; 462():368-74. PubMed ID: 26479200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles.
    Trotta V; Pavan B; Ferraro L; Beggiato S; Traini D; Des Reis LG; Scalia S; Dalpiaz A
    Eur J Pharm Biopharm; 2018 Jun; 127():250-259. PubMed ID: 29486302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.